Association Between TNF Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Network Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19
JAMA Netw Open 2021 Oct 01;4(10)e2129639, Z Izadi, EJ Brenner, SK Mahil, N Dand, ZZN Yiu, M Yates, RC Ungaro, X Zhang, M Agrawal, JF Colombel, MA Gianfrancesco, KL Hyrich, A Strangfeld, L Carmona, EF Mateus, S Lawson-Tovey, E Klingberg, G Cuomo, M Caprioli, AR Cruz-Machado, AC Mazeda Pereira, R Hasseli, A Pfeil, HM Lorenz, BF Hoyer, L Trupin, S Rush, P Katz, G Schmajuk, L Jacobsohn, AM Seet, S Al Emadi, L Wise, EL Gilbert, A Duarte-García, MO Valenzuela-Almada, CA Isnardi, R Quintana, ER Soriano, TY Hsu, KM D'Silva, JA Sparks, NJ Patel, RM Xavier, CDL Marques, AM Kakehasi, RM Flipo, P Claudepierre, A Cantagrel, P Goupille, ZS Wallace, S Bhana, W Costello, R Grainger, JS Hausmann, JW Liew, E Sirotich, P Sufka, PC Robinson, PM Machado, CEM Griffiths, JN Barker, CH Smith, J Yazdany, MD KappelmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.